Bioton S.A. Logo

Bioton S.A.

Develops and manufactures recombinant human insulin for global diabetes care solutions.

BIO | WAR

Overview

Corporate Details

ISIN(s):
PLBIOTN00029
LEI:
259400I5R1L3OPCGII81
Country:
Poland
Address:
Warszawa Starościńska 5, 02-516 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioton S.A. is an innovative biotechnology company specializing in providing comprehensive solutions for diabetes care. The company's core activities include the research, development, manufacturing, and commercialization of pharmaceutical products, with a primary focus on recombinant human insulin. Bioton manages the entire drug production process, from advanced R&D and the synthesis of active pharmaceutical ingredients to the distribution of finished medicinal products. Recognized as a leader in the Polish market, the company is also one of the top commercial manufacturers of recombinant human insulin globally, operating from its modern production facility near Warsaw.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-30 17:06
Raport Kwartalny Q3 2025
Polish 1.3 MB
2025-10-30 17:06
Śródroczne SSF Grupy Bioton S.A. za Q3 2025
Polish 1.2 MB
2025-09-17 19:17
Bioton S.A. Wybrane dane w EUR Jednostkowe_1H 2025
Polish 441.3 KB
2025-09-17 19:17
Bioton S.A. Wybrane dane w EUR Jednostkowe_1H 2025
Polish 442.7 KB
2025-09-17 19:17
Raport z przeglądu śródrocznego skróconego SSF_MSSF skonsolidowane
Polish 235.8 KB
2025-09-17 19:17
Raport z przeglądu śródrocznego skróconego JSF_MSSF jednostkowe
Polish 233.3 KB
2025-09-17 19:17
Sprawozdanie_Zarzadu_1H 2025
Polish 1.7 MB
2025-09-17 19:17
Sprawozdanie finansowe_ŚSSF_1H 2025 skonsolidowane
Polish 1.1 MB
2025-09-17 19:17
Sprawozdanie finansowe_ŚJSF_1H 2025 jednostkowe
Polish 1.2 MB
2025-08-20 15:55
Zmiana terminu publikacji skonsolidowanego "rozszerzonego" raportu półrocznego …
Polish 774 bytes
2025-07-29 17:13
Romuald Harwas życiorys
English 150.3 KB
2025-07-29 17:13
Powołanie Członka Zarządu - Content (PL)
Polish 1.1 KB
2025-07-29 17:04
Rezygnacja Członka Zarządu - Content (PL)
Polish 346 bytes
2025-07-25 15:29
Otrzymanie zawiadomienia na podstawie art. 69 Ustawy o ofercie publicznej i war…
Polish 2.5 KB
2025-06-24 12:04
Xia Kaiguo CV
English 131.3 KB

Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioton S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioton S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France
ABVX
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.